Key facts
- It has raised $9.7M; the latest was Later Stage VC in Feb 2025.
- Notable investors include High-Tech Gründerfonds, Bundesministerium für Wirtschaft und Klimaschutz, Bundesministerium für Bildung und Forschung, Business Angels Club Berlin-Brandenburg, German Accelerator — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for AudioCure
- ·The full record, as it builds
Funding rounds
No funding rounds for AudioCure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AudioCure
Operator of a medical research platform intended to offer treatment for incurable hearing loss. The company's platform focuses on the preclinical research and clinical development of novel pharmacotherapy to treat disorders of the inner ear, enabling patients to access the treatment of hearing disabilities.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2012
- Employees
- 16
- Website
- audiocure.com/
- Ownership
- Privately Held (backing)
AudioCure doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AudioCure shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AudioCure in its N-PORT filings yet. We sweep new filings monthly.